Mylan has entered into an agreement to buy the rights to Aspen Pharmacare’s thrombosis business in Europe for EUR 641.9 million ($756.8 million). Under the terms of the agreement, Mylan (MYL) will ...

Shares of Mylan (NASDAQ: MYL) were sinking 11.4% as of 11:09 a.m. EST on Wednesday. The drugmaker reported its fourth-quarter results after the market closed on Tuesday. Unfortunately, there was very ...

Sanofi has long argued that generics giant Mylan used anticompetitive practices to market its popular epinephrine autoinjector EpiPen, specifically scuppering the launch of its more "consumer-friendly ...

Mylan NV finalized a $465 million settlement with the U.S. Justice Department. The settlement resolves claims the pharmaceutical company overcharged the government for its EpiPen emergency allergy ...

Mylan's planned megamerger with Pfizer's Upjohn generics unit has had a rocky road to approval, with the novel coronavirus pandemic snagging regulatory review. Despite the delay, Mylan isn't twiddling ...

Comprehensive report includes a look at Mylan's historical impact on patients, employees, the environment, global public health and the community HERTFORDSHIRE, England and PITTSBURGH, May 4, 2020 ...

The myriad problems with the U.S. healthcare system aren’t the fault of any one person. But every so often, an industry executive spouts something so wrong-headed, it shines a helpful light on what we ...

Mylan, a company best known for generic drugs, watched its stock slide last year after it was named along with other generic-drug manufacturers in a case alleging price-fixing. The lawsuit, brought by ...

Mylan Inc, a part of global healthcare company Viatris, on Tuesday exited Biocon Ltd by selling its entire 5.64 per cent stake for Rs 3,679 crore through open market transactions. A total of ...